Dentists in Mt Pleasant, WI Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. Abbey Lynn Christopherson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2860 S Green Bay Rd, Mt Pleasant, WI 53406 Phone: 262-955-1091 |
 Simran Pal Singh, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6100 Washington Ave Ste F2, Mt Pleasant, WI 53406 Phone: 262-999-9998 |
Adam Joseph Pamer, D.D.S. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1320 S Green Bay Rd, Mt Pleasant, WI 53406 Phone: 262-358-9302 |
Lauren Murray Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 5820 Washington Ave, Mt Pleasant, WI 53406 Phone: 262-770-5848 |
Asad Farooq, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6100 Washington Ave Ste F2, Mt Pleasant, WI 53406 Phone: 262-999-9998 |
Dr. Maria Barnes, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5439 Durand Ave Ste 215, Mt Pleasant, WI 53406 Phone: 262-634-8662 |
News Archive
Skin dendritic cells promote distinct and opposing antigen-specific responses
A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same type of infection.
Circadian Technologies granted significant European patent
Circadian Technologies Limited (ASX:CIR) announced today that its subsidiary company, Vegenics Limited, has been granted European Patent 1749836 covering the use of VEGF-D protein and antibodies to VEGF-D in a broad spectrum of therapeutic indications, including the treatment of cancer.
Phase III RE-LY study results to be presented at the European Society of Cardiology Congress
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
ACA Medicaid expansion linked to decline in uninsured hospitalizations for cardiovascular events
Medicaid expansion under the Affordable Care Act was associated with a decline in the proportion of uninsured hospitalizations for major cardiovascular events such as heart attack, stroke and heart failure.
Chagas disease causes chronic heart disease and has spread outside of Latin America
Chagas disease, caused by infection with a parasite called Trypanosoma cruzi (T cruzi), causes chronic heart disease in about one third of those infected.
› Verified 2 days ago
Dentists
Occupational Therapists
Counselors
Psychologists
Clinical Social Workers
Pharmacists